Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

STACCATO · European Industrial Doctorate for enhancing upstream biopharmaceutical manufacturing process development through single cell analysis

H2020Status: CLOSED1 January 201931 December 2022EU funding €2,924,526Call H2020-MSCA-ITN-2018

Our ability to utilise biological systems to produce medicines has improved the quality of life for millions of EU citizens. In recent years a new wave of exciting biopharmaceuticals have been discovered with the potential to advance current treatments for a variety of disorders. These new medicines, however, are becoming increasingly complex and difficult to manufacture. Overcoming the inherent heterogeneity of cells grown in vitro to produce effective, uniform and safe biopharmaceuticals is one of the most significant challenges faced by industry today.The STACCATO European Industrial Doctorate has been specifically designed to strengthen Europe’s innovation capacity and leadership in the BioPharma sector. The consortium will provide exceptional intersectoral training to 11 ESRs through pioneering research focused on harnessing recent advances in single cell analysis to generate and apply a new suite of tools for cell culture process development. ESRs will participate in a specialised training programme to build their proficiency in essential research and industry disciplines. Additional training in professional skills and entrepreneurship will enable ESRs to become future leaders in biopharmaceutical manufacturing science.STACCATO is composed of an industry leader in instrumentation for cellular analysis, 3 innovative biotechnology SMEs, a leading academic institution and a research conducting biological medicines regulatory agency. The STACCATO EID will immerse all ESRs in highly dynamic industrial environments while receiving supervision from leading academics. A feature of STACCATO is collaboration amongst experts in the production of different biopharmaceuticals such as therapeutic proteins and CAR T cell therapy. All ESRs will receive unparalleled exposure to pan-biopharmaceutical manufacturing challenges to foster collaboration, catalyse synergies across the network and ultimately create a truly unique training experience.

Consortium · 16 organisations

coordinator

NATIONAL INSTITUTE FOR BIOPROCESSING RESEARCH AND TRAINING LIMITED

IE · €824,053

partner

NORTHX BIOLOGICS MATFORS AB

SE

partner

HELSINGIN YLIOPISTO

FI

partner

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN

IE

participant

KUNGLIGA TEKNISKA HOEGSKOLAN

SE · €563,966

partner

SPIBER TECHNOLOGIES AB

SE

participant

BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

DE · €505,577

participant

TILT BIOTHERAPEUTICS OY

FI · €280,806

partner

MEIRAGTX UK II LTD

UK

partner

UNIVERSIDADE NOVA DE LISBOA

PT

partner

AVECTAS LIMITED

IE

partner

TECHNISCHE UNIVERSITAT DARMSTADT

DE

participant

BECTON DICKINSON RESEARCH CENTRE IRELAND LIMITED

IE · €274,684

partner

ACCELOPMENT SCHWEIZ AG

CH

partner

Horizon Discovery Limited

UK

participant

INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLOGICA

PT · €475,440

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.